Aihol Corporation
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 12, 2027The maintenance fee for Composition for use in treating and preventing inflammation related disorder (US 10,471,151) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,370,575 | Composition for use in treating and preventing inflammation related disorder In force · From the USPTO record | In force | From the USPTO record | |
| US 10,471,151 | Composition for use in treating and preventing inflammation related disorder In force · From the USPTO record | In force | From the USPTO record | |
| US 10,709,731 | Materials for treating and preventing mucosa related disease In force · From the USPTO record | In force | From the USPTO record | |
| US 9,539,265 | Pharmaceutical formulation containing glycosaminoglycan In force · From the USPTO record | In force | From the USPTO record | |
| US 11,524,079 | Hyaluronan Conjugates and Uses Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,458,204 | Method for improving substitution rate and/or substitution efficiency of hyaluronan-drug conjugates In force · From the USPTO record | In force | From the USPTO record | |
| US 12,128,108 | Hyaluronan Conjugates and Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,643,431 | Uses of Hyaluronan Conjugate In force · High confidence | In force | High confidence | |
| US 12,281,133 | Hyaluronan Conjugate In force · High confidence | In force | High confidence | |
| US 12,521,351 | Delayed Release Oral Pharmaceutical Composition In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 2 no status recorded